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Abstract
Background: Women with type 1 diabetes (T1D) have a four-fold increased risk for cardiovascular disease (CVD)
compared to non-diabetic (non-DM) women, as opposed to double the risk in T1D men compared to non-DM men. It
is unclear how early in life CVD risk differences begin in T1D females. Therefore, our objective was to compare CVD risk
factors in adolescents with and without T1D to determine the effects of gender on CVD risk factors.
Methods: The study included 300 subjects with T1D (age 15.4±2.1 years, 50 % male, 80 % non-Hispanic White (NHW),
glycated hemoglobin (A1c) 8.9±1.6 %, diabetes duration 8.8±3.0 years, BMI Z-score 0.62±0.77) and 100non-DM controls
(age 15.4±2.1 years, 47 % male, 69 % NHW, BMI Z-score 0.29±1.04). CVD risk factors were compared by diabetes status
and gender. Multivariate linear regression analyses were used to determine if relationships between diabetes status
and CVD risk factors differed by gender independent of differences in A1c and BMI.
Results: Differences in CVD risk factors between T1D subjects and non-DM controls were more pronounced in girls.
Compared to boys with T1D and non-DM girls, T1D girls had higher A1c (9.0 % vs. 8.6 % and 5.1 %, respectively), BMI
Z-score (0.70 vs. 0.47 and 0.27), LDL-c (95 vs. 82 and 81 mg/dL), total cholesterol (171 vs. 153 and 150 mg/dL), DBP (68
vs. 67 and 63 mmHg), and hs-CRP (1.15 vs. 0.57 and 0.54 mg/dL) after adjusting for Tanner stage, smoking status, and
race/ethnicity (p <0.05 for all). In T1D girls, differences in lipids, DBP, and hs-CRP persisted even after adjusting for
centered A1c and BMI Z-score.
Testing interactions between gender and T1D with CVD risk factors indicated that differences were greater between
girls with T1D and non-DM compared to differences between boys with T1D and non-DM. Overall, observed increases
in CVD risk factors in T1D girls remained after further adjustment for centered A1c or BMI Z-score.
Conclusions: Interventions targeting CVD risk factors in addition to lowering HbA1c and maintaining healthy BMI are
needed for youth with T1D. The increased CVD risk factors seen in adolescent girls with T1D in particular argues for
earlier intervention to prevent later increased risk of CVD in women with T1D.
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Background
Although microvascular outcomes for people with type
1 diabetes (T1D) have improved, cardiovascular disease
(CVD) remains the leading cause of death for people
with T1D [1] and mortality is still higher than in adults
without diabetes (non-DM) [2]. Atherosclerotic changes
are known to begin in adolescence in the general
population [3–5] and CVD occurs earlier in life and
more frequently among people with T1D than in the
general population [6]. Women with T1D have at least a
four-fold increased risk of CVD compared to non-DM
women, as opposed to a doubling of risk in men with
T1D compared to non-DM men [7–9]. It is not clear
how early in life CVD risk differences begin in females
with T1D.
Several other factors have been identified as contribut-
ing to increased CVD risk in adults with T1D compared
to non-DM including glycemic control and adiposity.
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Intensive insulin therapy resulted in lower glycated
hemoglobin (A1c), reduced CVD events and mortality in
the Diabetes Control and Complications Trial (DCCT)/
Epidemiology of Diabetes Interventions and Complica-
tions (EDIC) study [10, 11]. However, in the DCCT
more intensive glycemic control was associated with in-
creased BMI, which was more pronounced in adoles-
cents than in adults [12]. Similarly in adolescents, data
from the SEARCH for Diabetes in Youth (SEARCH)
study indicate that adolescents with T1D are frequently
overweight and obese (22.1 % and 12.6 %, respectively)
and were more likely to be overweight than non-diabetic
children assessed by the National Health and Nutrition
Survey (NHANES) [13]. While not explored in this
study, more intensive insulin treatment is likely a con-
tributor [13]. In a recent multinational comparison from
the T1D Exchange and the DPV registry median BMI
values in youth with T1D were greater than international
and their respective national reference values [14].Thus,
the added improvement of one major CVD risk factor
(A1c) can lead to worsening of another (BMI). However,
both weight and glycemic control can be especially diffi-
cult for girls with T1D, though it is unclear if increased
BMI and A1c for girls during adolescence are the sole
factors contributing to increased CVD risk, or if there
are other possible risks in girls that are currently un-
accounted for [15].
Therefore, our objective was to compare CVD risk fac-
tors – glycemic control, BMI, cholesterol, blood pressure,
and inflammation - in girls compared to boys to deter-
mine how gender affects the relationship of diabetes status
with CVD risk. Next, we sought to examine whether these
differences are independent of differences in glycemic
control and weight by gender and diabetes status.
Methods
Study subjects
A cross-sectional study design was used to assess CVD
risk factors in youth with and without T1D. At enroll-
ment, subjects were ages 12-19 years and those with
T1D were diagnosed by a pediatric endocrinologist,
treated with insulin, had diabetes duration over 5 years
at entry into the study, and received care at the Barbara
Davis Center for Childhood Diabetes (BDC). Non-
diabetic control subjects were friends of study subjects
or recruited from campus and community advertise-
ments, and were required to be free from diagnosed dia-
betes. All had normal fasting glucose and HbA1c levels.
No siblings or first-degree relatives of patients with T1D
were included. Subjects were excluded for diabetes of any
other type, or for a history of abnormal cardiac anatomy
or arrhythmia that would preclude the subject from vascu-
lar function measurements. The study was approved by
the Colorado Multiple Institution Review Board and
informed consent and assent (for subjects <18 years
of age) was obtained in all subjects prior to participa-
tion in the study.
Study visit
All subjects fasted overnight (≥8 hours) and were asked
to refrain from caffeine intake and smoking within
8 hours prior to study visit (to avoid potential effect on
vascular measures). Tanner stage for all BDC patients
was assessed by a clinician investigator or by the sub-
ject’s BDC provider. Non-diabetic subjects were re-
quested to have Tanner stage assessed by a clinician
investigator with the option of self-assessment if the
subject refused a physical exam. Medical history was ob-
tained with standardized questionnaires including
methods of insulin administration (injections vs. insulin
pump use), dietary habits, and tobacco use. Blood pres-
sure measurements were obtained after a 5 minute rest
using a Dynapulse 5200A (PulseMetric, Inc., San Diego,
CA) and 3 measurements were averaged. Height was
measured by a wall-mounted stadiometer to the nearest
0.1 cm with shoes removed and weight by a Detecto scale
to the nearest 0.1 kg [16, 17]. BMI Z-scores were calcu-
lated based on the 2000 Centers for Disease Control and
Prevention age and gender specific standards [18].
Laboratory assays
A1c was measured using the DCA Vantage (Siemens,
Malvern, PA) at the Children’s Hospital Colorado (Aurora,
CO) main clinical lab. Measurements for total cholesterol,
triglycerides, and HDL- cholesterol were performed in
the University of Colorado Hospital (UCH) Clinical
and Translational Research Center (CTRC) Core lab
using Olympus AU400e Chemistry. LDL- cholesterol
was calculated using the Friedewald formula [19]. High-
sensitivity C-reactive protein (hs-CRP) was measured at
the Children’s Hospital Colorado (Aurora, CO) CTRC
core lab utilizing a multiplex assay platform Siemens (for-
mally Dade Behring) BNII Nephelometer.
Statistical analysis
Participant characteristics were stratified by both diabetes
status and gender and examined. Data are presented as
means ± SD for continuous variables, geometric mean and
range for continuous variables with non-normal distribu-
tion, or count and % for categorical variables. Triglycer-
ides (Tg) and hs-CRP were log-transformed for analysis
due to non-normal distribution and expressed as mean
and range in Table 1. Because of multicollinearity between
A1c and diabetes status, a centered A1c variable was cal-
culated which represented absolute deviations from the
mean A1c in both participants with and without T1D to
allow for adjustment of A1c [20, 21]. Use of this statistical
method to calculate deviation from the mean within a
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group allows for comparison of variability from the mean
between 2 groups with non-overlapping distributions,
which is expected for A1c in populations with and without
T1D. Stratified two sample t-tests were used to look at dif-
ferences across groups for continuous variables, and chi
square tests were used to look for differences for categor-
ical variables.
The relationship of gender and CVD risk factors were
compared between youth with T1D and non-DM youth.
Multivariable linear regression was used to calculate ad-
justed least square means to test the relationships of
CVD risk factors by gender stratified by diabetes status.
Interactions for the relationship between diabetes status
and the CVD risk factors by gender were tested. Interac-
tions with p-values less than 0.10 were considered
significant. Pair-wise comparisons were made for
CVD risk factors stratified by gender and diabetes
status. CVD risk factors adjusted for Tanner stage,
race/ethnicity, and smoking status were compared by
gender for youth with and without T1D and also by
diabetes status for each gender.
Secondary analyses were conducted to separately in-
vestigate the influence of A1c and BMI Z-score on CVD
risk factors comparing youth with T1D to non-DM
youth testing for adjusted least square means and inter-
actions stratified by diabetes status and centered A1c
and BMI Z-score. Statistical analyses were performed
using SAS software, version 9.3 of the SAS System for
Windows.
Results
A total of 400 participants enrolled in the study (T1D
n = 300, Non-DM n = 100). Distributions for age, gen-
der, current smoking status, and Tanner stage were
similar between participants with and without T1D
(Table 1). Participants with T1D had mean diabetes dur-
ation of 8.8 ± 3.0 years and 55 % were on insulin pumps.
Gender differences
When stratified by diabetes status and gender
(Table 1), girls with T1D had higher A1c compared to
boys with T1D (p = 0.01). Girls with T1D had higher
Table 1 Unadjusted characteristics by sex and diabetes status
Variable Non-diabetic controls N = 100 Type 1 diabetes subjects N = 300
Boys (n = 47) Girls (n = 53) Boys (n = 152) Girls (n = 148)
Age, years1 14.9 ± 2.1 15.8 ± 2.0 15.6 ± 2.1 15.2 ± 2.1
Race-ethnicity, % NHW3 66 % 72 % 80 % 80 %
Type 1 diabetes duration, years – – 8.9 ± 2.9 8.6 ± 3.1
Current smoker, %2 2 % 9 % 11 % 3 %
Tanner stage, %1,2
I 6 % 2 % 5 % 1 %
II 17 % 2 % 12 % 3 %
III 9 % 20 % 10 % 10 %
IV 34 % 21 % 20 % 35 %
V 34 % 55 % 53 % 51 %
A1c, %2,3,4 5.3 ± 0.3 5.3 ± 0.3 8.7 ± 1.5 9.2 ± 1.7
Centered A1c2 0.0 ± 0.3 0.0 ± 0.3 -0.3 ± 1.5 0.2 ± 1.7
BMI Z-score2,3,4 0.18 ± 1.14 0.39 ± 0.94 0.46 ± 0.78 0.76 ± 0.71
Total cholesterol, mg/dl2,4 142 ± 27 149 ± 29 148 ± 29 165 ± 36
Triglyceridesa, mg/dl 70(34-163) 82(43-235) 74(27-326) 78(28-394)
HDL-c, mg/dl1,2,4 46 ± 8 50 ± 10 49 ± 9 54 ± 11
LDL-c, mg/dl2,4 81 ± 23 81 ± 23 83 ± 22 94 ± 29
SBP, mmHg1,2,3,4 111 ± 9 107 ± 8 115 ± 9 112 ± 8
DBP, mmHg2,3,4 64 ± 6 64 ± 6 68 ± 7 69 ± 6
Hs-CRPa, mg/dl2,4 0.31(0.03-5.85) 0.48(0.02-9.07) 0.46(0.05-9.2) 0.91(0.04-22)
ageometric mean (range)
NHW = non-Hispanic White
1p < 0.05 for boys vs. girls Non-DM
2p < 0.05 for boys vs. girls with type 1 diabetes
3p < 0.05 for Non-DM vs. type 1 diabetes boys
4p < 0.05 for Non-DM vs. type 1 diabetes girls
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BMI Z-score (p = 0.002), total cholesterol (p = <0.0001),
LDL-c (p = <0.0001), SBP (p = 0.003), DBP (p = 0.04) and
hs-CRP (p = <0.0001) compared to boys with T1D. Girls
with T1D also had higher HDL-c (p = <0.0001) than boys
with T1D. In the non-DM participants, boys had higher
SBP (p = 0.008) than girls and HDL-c (p = 0.053) was mar-
ginally lower, but there were no significant differences in
BMI Z-score, total cholesterol, triglycerides, LDL-c, DBP,
or hs-CRP.
Comparing CVD risk factors by diabetes status for
each gender, girls with T1D had higher A1c (p < 0.0001),
BMI Z-score (p = 0.005), total cholesterol (p = 0.002),
LDL-c (p = 0.001), SBP (p = 0.0006), DBP (p < 0.0001),
and hs-CRP (p = 0.002) compared to non-DM girls. Girls
with T1D also had higher HDL-c (p = 0.03). In contrast,
boys with T1D had higher A1c (p < 0.0001), BMI Z-score
(p = 0.04), SBP (p = 0.03), and DBP (p < 0.0001), but had
similar total cholesterol, triglycerides, HDL-c, LDL-c,
and hs-CRP compared to non-DM boys.
Overall, 6.8 % of study participants reported that they
were current smokers. Girls with T1D were less likely to
be smokers than boys with T1D (p = 0.02), while the dif-
ferences in smoking status between girls with and without
T1D (p = 0.08), boys with and without T1D (p = 0.07), and
non-DM boys and non-DM girls (p = 0.12) were not
significantly different. Because the differences in smoking
status reached or approached statistical significance in all
comparisons, we adjusted for smoking in subsequent
analyses.
Age was significantly different between non-DM boys
and girls (non-DM boys: 14.9 ± 2.1 years vs. girls 15.8 ±
2.0 years, p = 0.04), while Tanner stage distribution was
similar for boys with and non-DM (p = 0.06) as well as
for girls with and non-DM (p = 0.18). As expected, the
Tanner stage distribution was significantly different for
boys compared to similar age girls with T1D (p = 0.001),
as well as for non-DM participants in that girls had
more advanced Tanner stage compared to boys, regard-
less of diabetes status (Table 1, p = 0.01). We adjusted
for Tanner stage instead of age in order to account for
any difference in pubertal status related to age difference
between groups. There were no significant differences by
diabetes status and gender with regards to race/ethnicity,
except that a higher percentage of boys with T1D were
NHW compared to non-diabetic boys (p = 0.04). Boys and
girls with T1D also had similar diabetes duration (p = 0.35).
Mean levels for CVD risk factors (A1c, BMI Z-score,
blood pressure, lipids, hs-CRP) adjusted for Tanner
stage, race/ethnicity, and smoking status are shown by
diabetes and gender status in Fig. 1. More atherogenic
profiles were seen in univariate analysis in girls with
T1D compared to both boys with T1D and non-DM
girls. Specifically, girls with T1D had higher A1c, BMI Z-
score, total cholesterol, LDL-c, DBP, and hs-CRP than
boys with T1D and non-DM girls (p < 0.05 for all). Add-
itionally, girls with T1D had higher SBP than non-DM
girls. Boys with T1D had a similar CVD risk profile com-
pared to non-DM boys, except for higher A1c, BMI Z-
score and DBP. Girls with T1D also had higher adjusted
HDL-c than boys with T1D and non-DM girls. There
were significant diabetes by gender interactions for total
cholesterol (p = 0.04), LDL-c (p = 0.02), and hs-CRP
(p = 0.07). These interactions indicate that for these spe-
cific CVD risk factors, differences were much greater
between girls with and without T1D compared to the dif-
ferences between boys with and without T1D.
To further investigate the more atherogenic CVD risk
profile observed in girls with T1D, secondary analyses
were performed with additional adjustment for BMI Z-
score and centered A1c, to determine if the interactions
by gender and diabetes were independent after account-
ing for the relationships between CVD risk factors and
BMI and A1c (Table 2). Adjustment for centered A1c
and BMI Z-score attenuated interactions between dia-
betes and gender for hs-CRP (p = 0.25) and total choles-
terol (p = 0.12), while gender continued to be a
significant effect modifier in the relationship between
diabetes status and LDL-c (p = 0.04). In spite of the de-
cline of significant interactions, the significant trends in
increased least squared means CVD risk factors in girls
with T1D that were observed in Table 1 and Fig. 1
remained after further adjustment for centered A1c or
BMI Z-score, suggesting that girls with T1D have a
worse CVD risk factor profile, independent of their in-
creased BMI Z-score and A1c.
A1c and BMI differences
In a separate analysis, interactions with diabetes status
and centered A1c as well as diabetes status and BMI Z-
score (data not shown) were examined to assess how the
relationship between diabetes status and CVD risk fac-
tors varied by A1c and BMI. The same CVD risk factors
were considered and the models were adjusted for
Tanner stage, race/ethnicity, and smoking status. None
of the relationships between diabetes status and CVD
risk factors varied by centered A1c, meaning there were
no significant interactions. Similarly, the relationship be-
tween CVD risk factors and diabetes status did not vary
by BMI Z-score, indicating that the relationship between
diabetes status and CVD risk profile does not appear to
be dependent on the BMI or A1c of the participants.
Discussion
In this study, adolescent girls with T1D had a signifi-
cantly worse CVD risk profile compared to non-DM
girls and boys with T1D. Specifically, girls with T1D had
higher BMI Z-score, A1c, hs-CRP, total cholesterol, and
LDL-c. In contrast, adolescent boys with T1D had a





Fig. 1 a-h: Least Square Means for CVD risk factors stratified by gender and diabetes status and adjusted by Tanner stage, race/ethnicity, and
smoking status. P-values for each respective pair-wise test are also presented in each panel. 1a-HbA1c, 1b-BMI z-score, 1c-total cholesterol,
1d-HDL-c, 1e-LDL-c, 1f-SBP, 1g-DBP, 1h-hs-CRP
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similar CVD risk profile to non-DM boys. The higher
CRP and lipid levels observed in girls with T1D were not
entirely explained by higher BMI and A1c when com-
pared to both boys with T1D and non-DM girls. In
addition, secondary analyses indicate that A1c and BMI
do not modify the relationship between T1D status and
the measured CVD risk factors, while gender appears to
modify many of these relationships with more athero-
genic CVD risk factors in adolescent girls with T1D. A
recent study by Cree-Green et al. similarly found that fe-
male, but not male, adolescents with T1D had more
atherogenic lipoprotein subfraction distribution which
was correlated with insulin resistance [22].
Previous studies indicate that adults with T1D have
shorter life expectancies compared to adults without dia-
betes where women with T1D lose nearly 13 years on
average compared to non-diabetic women with 31 % of
this difference attributed to heart disease [9, 23, 24].
Other studies have shown that girls with T1D have in-
creased difficulty with maintaining a normal weight and
glycemic control during adolescence [15, 25] and have
worse lipid levels compared to their male counterparts
[26]. The SEARCH for Diabetes in Youth Study found
that girls with T1D showed a decrease in health-related
quality of life as they aged through adolescence while
boys saw an increase in their health-related quality of life
during the same ages with physical activity and weight
gain being major contributors to sex differences [27].
Other risk factors for increased CVD risk in adolescents
with T1D have also been identified, such as increased
consumption of sugary drinks [28], poor diet [29] and
decreased physical activity [30]. In a previous analysis
published on this cohort, we did not observe a difference
in diet or physical activity between girls and boys with
T1D indicating that these factors are likely not contrib-
uting to observed differences within adolescents with
T1D [5]. Though, some reports have shown a decrease
in physical activity in girls with T1D compared to girls
without diabetes [31].
However, the Coronary Artery Calcification in T1D
(CACTI) study and other T1D cohorts have shown that
adult women with T1D have similar BMI and A1c levels
compared to men with T1D [7, 8]. Therefore, it is pos-
sible that even when women with T1D are able to im-
prove their weight and glycemic control as adults,
damage done during adolescence may still adversely
affect their long-term CVD risk. Our findings suggest
that women with T1D may have an increased risk for
CVD events due to physiologic phenomenon that hap-
pens to girls during adolescence, in addition to exposure
to higher A1c levels and other CVD risk factors even if
these factors are improved in adulthood.
Other potential pathophysiologic pathways that may
contribute to elevated early CVD risk in adolescent girls
with T1D should be explored. For example, this study
could indicate that there is an additional factor or fac-
tors that impact both increased CVD risk factors (in-
cluding BMI) and glycemic control in women with T1D.
We know that women and girls with T1D experience in-
creased sex hormone and menstrual dysfunction com-
pared to women and girls without T1D [32] including
increased sex-hormone binding globulin and testoster-
one, as well as decreased estrogen [33, 34]. As a result,
females with T1D also have a higher prevalence of poly-
cystic ovarian syndrome [35], late menarche [36], irregu-
lar menstrual cycles, amenorrhea, and early menopause
[37, 38]. Menstrual dysfunction can persist despite im-
proved glycemic control [39–41]. Therefore, differences
in hormones and pubertal processes and interactions
with T1D and insulin treatment for the disease could
contribute to difficulties achieving optimal glycemic con-
trol and weight management, in addition to increased
Table 2 Cardiovascular disease risk factors by sex and diabetes status adjusted for mean centered A1c and BMI Z-score in addition
to race/ethnicity, Tanner stage, and smoking status
Variable Non-DM Type 1 diabetes P-value for interaction
Gender Boys Girls Boys Girls All
Total cholesterol, mg/dl(2,4) 151 ± 6 154 ± 5 156 ± 5 171 ± 5 0.12
Triglyceridesa, mg/dl 82(70-96) 86(74-99) 83(73-95) 85(73-95) 0.62
HDL-c, mg/dl(1,2,3,4) 48 ± 2 53 ± 2 52 ± 2 57 ± 2 0.80
LDL-c, mg/dl (2,4) 84 ± 5 81 ± 4 85 ± 4 94 ± 4 0.04
SBP, mmHg(1,2,4) 112 ± 1 105 ± 1 113 ± 1 108 ± 1 0.26
DBP, mmHg(3,4) 64 ± 1 63 ± 1 67 ± 1 68 ± 1 0.30
hs-CRPa, mg/dl(2,4) 0.52(0.34-0.80) 0.62(0.42-0.92) 0.64(0.45-0.91) 1.03(0.72-1.48) 0.25
Data are mean ± SE unless otherwise indicated
1p < 0.05 for non-DM boys vs. girls
2p < 0.05 for boys vs. girls with T1D
3p < 0.05 for Non-DM vs. T1D boys
4p < 0.05 for Non-DM vs. T1D girls
adenotes geometric least square mean and 95 % confidence interval
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inflammation, with worse effects in girls with T1D. Add-
itionally, the loss of estrogen protection early in adoles-
cence and greater insulin resistance could contribute to the
increased dyslipidemia observed in this population [8, 42].
There are limitations to these data. The data for this
analysis was collected cross-sectionally and participants
with T1D and non-DM may not be representative of the
underlying populations from which they were recruited.
However, elevated BMI and A1c in adolescent girls with
T1D have been observed elsewhere [15, 25]. Our find-
ings expand upon those studies to highlight the in-
creased CVD risk found in adolescent girls with T1D
compared to boys with T1D or non-DM adolescent girls.
Moreover, the increased CVD risk factors are independ-
ent of BMI and A1c.
Future research should focus more on girls with T1D
to explore other factors that make this group especially
susceptible to increased CVD risk. Additionally, the ob-
served relationships should be investigated over time to
understand at what stage in development the weight and
glycemic control have more impact on development of
CVD in adults with T1D and how gender and CVD risk
in adolescence relates to CVD outcomes later in life. Fi-
nally, special clinical consideration and therapeutic inter-
ventions should be targeted towards young girls with
T1D to address CVD risk factors in addition to achiev-
ing A1c targets and maintaining healthy weight to pre-
vent later diabetic complications.
Conclusions
Adolescent girls with T1D have a worse CVD risk profile
compared to non-DM girls and boys with T1D. In this
study, we found that girls with T1D had higher BMI Z-
score, A1c, hs-CRP, total cholesterol, and LDL-c. In con-
trast, adolescent boys with T1D had a similar CVD risk
profile to non-DM boys. Interventions targeting CVD
risk factors, lowering HbA1c and maintaining healthy
BMI are needed for youth with T1D and may be espe-
cially important for adolescent girls with T1D.
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